

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.16443235 |
| 2 | protein maturation by protein folding (GO:0022417) | 4.70510881 |
| 3 | glutamate secretion (GO:0014047) | 4.45428154 |
| 4 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.44707717 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.38568104 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.30906699 |
| 7 | synaptic vesicle maturation (GO:0016188) | 4.30780973 |
| 8 | neuronal action potential propagation (GO:0019227) | 4.13562841 |
| 9 | GDP-mannose metabolic process (GO:0019673) | 4.02617063 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.00419527 |
| 11 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.94388784 |
| 12 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.94388784 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.91632671 |
| 14 | lysine metabolic process (GO:0006553) | 3.81837317 |
| 15 | lysine catabolic process (GO:0006554) | 3.81837317 |
| 16 | negative regulation of microtubule polymerization (GO:0031115) | 3.81392288 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 3.79779322 |
| 18 | mitochondrial calcium ion transport (GO:0006851) | 3.74222163 |
| 19 | metallo-sulfur cluster assembly (GO:0031163) | 3.70162369 |
| 20 | iron-sulfur cluster assembly (GO:0016226) | 3.70162369 |
| 21 | neurotransmitter secretion (GO:0007269) | 3.61187078 |
| 22 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.55393539 |
| 23 | protein insertion into membrane (GO:0051205) | 3.46760699 |
| 24 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.44422150 |
| 25 | L-phenylalanine metabolic process (GO:0006558) | 3.43691153 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.43691153 |
| 27 | protein targeting to mitochondrion (GO:0006626) | 3.41707185 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 3.39183970 |
| 29 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.38610766 |
| 30 | succinate metabolic process (GO:0006105) | 3.34945020 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.31382675 |
| 32 | L-phenylalanine catabolic process (GO:0006559) | 3.31382675 |
| 33 | vocalization behavior (GO:0071625) | 3.31369875 |
| 34 | locomotory exploration behavior (GO:0035641) | 3.31167778 |
| 35 | establishment of protein localization to mitochondrion (GO:0072655) | 3.26634836 |
| 36 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.24828463 |
| 37 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.21499035 |
| 38 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.19389031 |
| 39 | nucleotide salvage (GO:0043173) | 3.18404442 |
| 40 | NADH metabolic process (GO:0006734) | 3.17643317 |
| 41 | regulation of mitochondrial translation (GO:0070129) | 3.17080091 |
| 42 | purine nucleotide salvage (GO:0032261) | 3.16497016 |
| 43 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.16385411 |
| 44 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.15438182 |
| 45 | gamma-aminobutyric acid transport (GO:0015812) | 3.15091581 |
| 46 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.13618324 |
| 47 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.11973063 |
| 48 | proline biosynthetic process (GO:0006561) | 3.11615513 |
| 49 | tricarboxylic acid cycle (GO:0006099) | 3.10522725 |
| 50 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.08524737 |
| 51 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.08058654 |
| 52 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.07412587 |
| 53 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.06893940 |
| 54 | aspartate family amino acid catabolic process (GO:0009068) | 3.06701593 |
| 55 | GTP biosynthetic process (GO:0006183) | 3.06645636 |
| 56 | negative regulation of necrotic cell death (GO:0060547) | 3.06114397 |
| 57 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.05682114 |
| 58 | cysteine metabolic process (GO:0006534) | 3.05442272 |
| 59 | activation of protein kinase A activity (GO:0034199) | 3.03988240 |
| 60 | protein localization to mitochondrion (GO:0070585) | 3.03791062 |
| 61 | protein localization to synapse (GO:0035418) | 3.02735402 |
| 62 | histone arginine methylation (GO:0034969) | 3.00343605 |
| 63 | mitochondrial fusion (GO:0008053) | 2.99521442 |
| 64 | pyrimidine nucleoside salvage (GO:0043097) | 2.99517711 |
| 65 | pyrimidine-containing compound salvage (GO:0008655) | 2.99517711 |
| 66 | regulation of oxidative phosphorylation (GO:0002082) | 2.99376017 |
| 67 | cellular ketone body metabolic process (GO:0046950) | 2.98535326 |
| 68 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.96971824 |
| 69 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.96750138 |
| 70 | oxaloacetate metabolic process (GO:0006107) | 2.95410219 |
| 71 | proline transport (GO:0015824) | 2.95355565 |
| 72 | protein retention in ER lumen (GO:0006621) | 2.88971482 |
| 73 | 2-oxoglutarate metabolic process (GO:0006103) | 2.88138335 |
| 74 | neuromuscular process controlling posture (GO:0050884) | 2.88108667 |
| 75 | exploration behavior (GO:0035640) | 2.87471736 |
| 76 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.86722655 |
| 77 | chaperone-mediated protein transport (GO:0072321) | 2.86432859 |
| 78 | positive regulation of mitochondrion organization (GO:0010822) | 2.86415464 |
| 79 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.85760181 |
| 80 | UTP biosynthetic process (GO:0006228) | 2.85587293 |
| 81 | transferrin transport (GO:0033572) | 2.85085053 |
| 82 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.84270189 |
| 83 | ATP synthesis coupled proton transport (GO:0015986) | 2.84270189 |
| 84 | cell communication by electrical coupling (GO:0010644) | 2.81573058 |
| 85 | negative regulation of dendrite development (GO:2000171) | 2.80417207 |
| 86 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.80335203 |
| 87 | neurotransmitter transport (GO:0006836) | 2.79548291 |
| 88 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.78408212 |
| 89 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.77651735 |
| 90 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.77061636 |
| 91 | heme biosynthetic process (GO:0006783) | 2.76393963 |
| 92 | sodium ion export (GO:0071436) | 2.76008677 |
| 93 | nucleobase catabolic process (GO:0046113) | 2.75425871 |
| 94 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.75160628 |
| 95 | regulation of neurotransmitter levels (GO:0001505) | 2.74539102 |
| 96 | CTP metabolic process (GO:0046036) | 2.74228016 |
| 97 | CTP biosynthetic process (GO:0006241) | 2.74228016 |
| 98 | COPI coating of Golgi vesicle (GO:0048205) | 2.74051423 |
| 99 | Golgi transport vesicle coating (GO:0048200) | 2.74051423 |
| 100 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.73853708 |
| 101 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.73014159 |
| 102 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.71839314 |
| 103 | glutamate metabolic process (GO:0006536) | 2.71133560 |
| 104 | viral protein processing (GO:0019082) | 2.70470062 |
| 105 | peroxisome fission (GO:0016559) | 2.69605686 |
| 106 | virion assembly (GO:0019068) | 2.69337639 |
| 107 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.69085119 |
| 108 | respiratory electron transport chain (GO:0022904) | 2.68883518 |
| 109 | deoxyribonucleotide catabolic process (GO:0009264) | 2.68796148 |
| 110 | ribosomal small subunit biogenesis (GO:0042274) | 2.68645216 |
| 111 | peptidyl-arginine methylation (GO:0018216) | 2.68105297 |
| 112 | peptidyl-arginine N-methylation (GO:0035246) | 2.68105297 |
| 113 | layer formation in cerebral cortex (GO:0021819) | 2.67933805 |
| 114 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.67690927 |
| 115 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.67619618 |
| 116 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.67120201 |
| 117 | nucleoside salvage (GO:0043174) | 2.66535940 |
| 118 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.66176574 |
| 119 | cellular modified amino acid catabolic process (GO:0042219) | 2.66032371 |
| 120 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.65267352 |
| 121 | regulation of cellular respiration (GO:0043457) | 2.64968382 |
| 122 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.64944559 |
| 123 | glyoxylate metabolic process (GO:0046487) | 2.64442459 |
| 124 | electron transport chain (GO:0022900) | 2.64162158 |
| 125 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.62954746 |
| 126 | cellular potassium ion homeostasis (GO:0030007) | 2.61840327 |
| 127 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.61354626 |
| 128 | mitochondrion transport along microtubule (GO:0047497) | 2.61354626 |
| 129 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.61338023 |
| 130 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.60820192 |
| 131 | cell communication involved in cardiac conduction (GO:0086065) | 2.60552436 |
| 132 | positive regulation of TOR signaling (GO:0032008) | 2.59878212 |
| 133 | prostaglandin biosynthetic process (GO:0001516) | 2.59768470 |
| 134 | prostanoid biosynthetic process (GO:0046457) | 2.59768470 |
| 135 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.59222681 |
| 136 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.59222681 |
| 137 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.58740205 |
| 138 | establishment of viral latency (GO:0019043) | 2.58433717 |
| 139 | sulfur amino acid catabolic process (GO:0000098) | 2.58163467 |
| 140 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.58035819 |
| 141 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.57665811 |
| 142 | dicarboxylic acid catabolic process (GO:0043649) | 2.57249825 |
| 143 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.56802856 |
| 144 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.56768232 |
| 145 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.56570625 |
| 146 | phagosome maturation (GO:0090382) | 2.55491861 |
| 147 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.55142762 |
| 148 | de novo posttranslational protein folding (GO:0051084) | 2.54952795 |
| 149 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.54705683 |
| 150 | UTP metabolic process (GO:0046051) | 2.54526028 |
| 151 | alpha-linolenic acid metabolic process (GO:0036109) | 2.53951391 |
| 152 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.53252944 |
| 153 | aerobic respiration (GO:0009060) | 2.52745685 |
| 154 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.52598848 |
| 155 | regulation of mitochondrion organization (GO:0010821) | 2.52378011 |
| 156 | proteasome assembly (GO:0043248) | 2.52122267 |
| 157 | membrane depolarization during action potential (GO:0086010) | 2.52079190 |
| 158 | ferric iron transport (GO:0015682) | 2.51960883 |
| 159 | ketone body metabolic process (GO:1902224) | 2.50295538 |
| 160 | aromatic amino acid family catabolic process (GO:0009074) | 2.47715182 |
| 161 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.47707637 |
| 162 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.47399621 |
| 163 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.47399621 |
| 164 | gluconeogenesis (GO:0006094) | 2.45626785 |
| 165 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.45303483 |
| 166 | neuron cell-cell adhesion (GO:0007158) | 2.43136665 |
| 167 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.42914226 |
| 168 | cell migration in hindbrain (GO:0021535) | 2.42745929 |
| 169 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.42650988 |
| 170 | establishment of mitochondrion localization (GO:0051654) | 2.42253455 |
| 171 | synaptic vesicle endocytosis (GO:0048488) | 2.42108600 |
| 172 | short-chain fatty acid metabolic process (GO:0046459) | 2.41427566 |
| 173 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.40240992 |
| 174 | oxidative phosphorylation (GO:0006119) | 2.38137595 |
| 175 | positive regulation of synapse maturation (GO:0090129) | 2.38061917 |
| 176 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.37889909 |
| 177 | kynurenine metabolic process (GO:0070189) | 2.36040349 |
| 178 | axon cargo transport (GO:0008088) | 2.35851280 |
| 179 | synaptic transmission, glutamatergic (GO:0035249) | 2.35814773 |
| 180 | hexose biosynthetic process (GO:0019319) | 2.35723341 |
| 181 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.35710282 |
| 182 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.34443158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.42040781 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.96359008 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.88231637 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.60248330 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.75708223 |
| 6 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.73204494 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65535632 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.62096752 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.55426582 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.53397085 |
| 11 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.46009076 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.44000019 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.38266191 |
| 14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.37591153 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.37418858 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.37383928 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.37064575 |
| 18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.36340759 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21130803 |
| 20 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.17952160 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.06572465 |
| 22 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.06098301 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05265211 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.99987113 |
| 25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.97844768 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.97151248 |
| 27 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.93492227 |
| 28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.89319141 |
| 29 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.89026167 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88149511 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.87441905 |
| 32 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.87089354 |
| 33 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.84707173 |
| 34 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.81589038 |
| 35 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.79961763 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.78778531 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73267868 |
| 38 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.71109918 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69883546 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.69777449 |
| 41 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.69118829 |
| 42 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68647227 |
| 43 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.68462008 |
| 44 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.68373125 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.67438722 |
| 46 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.66604445 |
| 47 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.61170800 |
| 48 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.59517607 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.58600073 |
| 50 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.56192571 |
| 51 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55603170 |
| 52 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55603170 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.54638407 |
| 54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.53816182 |
| 55 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53764177 |
| 56 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.49226533 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48300463 |
| 58 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.48055314 |
| 59 | MYC_22102868_ChIP-Seq_BL_Human | 1.47602036 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47457763 |
| 61 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.46754010 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.45904032 |
| 63 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45533159 |
| 64 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45127395 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44617350 |
| 66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44230621 |
| 67 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.42312432 |
| 68 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.42218595 |
| 69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.41034277 |
| 70 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.39763533 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39104645 |
| 72 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.38476687 |
| 73 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38139455 |
| 74 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.36957240 |
| 75 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.35747165 |
| 76 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34984303 |
| 77 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.34029116 |
| 78 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.34008181 |
| 79 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32798538 |
| 80 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.32004959 |
| 81 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31536956 |
| 82 | MAF_26560356_Chip-Seq_TH2_Human | 1.31248841 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29056835 |
| 84 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28469323 |
| 85 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.27853570 |
| 86 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.27183837 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.27053858 |
| 88 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.25112365 |
| 89 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24904682 |
| 90 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24660000 |
| 91 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.24108137 |
| 92 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.23215490 |
| 93 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.22922476 |
| 94 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.21217524 |
| 95 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21156939 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20337608 |
| 97 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.19714025 |
| 98 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.19585111 |
| 99 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19409393 |
| 100 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.18955874 |
| 101 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.18526593 |
| 102 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.18342835 |
| 103 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18121893 |
| 104 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.17999967 |
| 105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16820609 |
| 106 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15890632 |
| 107 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14837494 |
| 108 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.13984276 |
| 109 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12879241 |
| 110 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.12461295 |
| 111 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.11702989 |
| 112 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11428878 |
| 113 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.11313926 |
| 114 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11126444 |
| 115 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09954413 |
| 116 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09803479 |
| 117 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09613292 |
| 118 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08671033 |
| 119 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08452798 |
| 120 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08359139 |
| 121 | * MAF_26560356_Chip-Seq_TH1_Human | 1.07840155 |
| 122 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.07090727 |
| 123 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07037649 |
| 124 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06795578 |
| 125 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06644641 |
| 126 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06188002 |
| 127 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06144741 |
| 128 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.05938337 |
| 129 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.05679338 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04915586 |
| 131 | P68_20966046_ChIP-Seq_HELA_Human | 1.04725274 |
| 132 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.04396701 |
| 133 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04215823 |
| 134 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.02147272 |
| 135 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01877619 |
| 136 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00835278 |
| 137 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.98951531 |
| 138 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98937414 |
| 139 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.98365686 |
| 140 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95523196 |
| 141 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95366078 |
| 142 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95104522 |
| 143 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.94013486 |
| 144 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.92371273 |
| 145 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.92187124 |
| 146 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91826665 |
| 147 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.89802977 |
| 148 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.89480665 |
| 149 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.89219444 |
| 150 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.86922725 |
| 151 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86500076 |
| 152 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.84183852 |
| 153 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83894647 |
| 154 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.81293998 |
| 155 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.80023935 |
| 156 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.79343671 |
| 157 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.78478772 |
| 158 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.78176343 |
| 159 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.76489215 |
| 160 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76471346 |
| 161 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.76450954 |
| 162 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.76031167 |
| 163 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.74956343 |
| 164 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.74657614 |
| 165 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.74020390 |
| 166 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.73505888 |
| 167 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.72753288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.64167627 |
| 2 | MP0005451_abnormal_body_composition | 3.85720759 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.84901163 |
| 4 | MP0004270_analgesia | 3.21299574 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.11472560 |
| 6 | MP0008260_abnormal_autophagy | 3.00379257 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 2.94299528 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.93973652 |
| 9 | MP0003880_abnormal_central_pattern | 2.82233889 |
| 10 | MP0005360_urolithiasis | 2.77866238 |
| 11 | MP0002736_abnormal_nociception_after | 2.60541399 |
| 12 | MP0002735_abnormal_chemical_nociception | 2.58570015 |
| 13 | MP0002822_catalepsy | 2.47647551 |
| 14 | MP0003329_amyloid_beta_deposits | 2.46581747 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.46369502 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.37637367 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.35780452 |
| 18 | MP0002653_abnormal_ependyma_morphology | 2.35165206 |
| 19 | MP0005365_abnormal_bile_salt | 2.33800548 |
| 20 | MP0009745_abnormal_behavioral_response | 2.27751754 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.24147703 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.23794948 |
| 23 | MP0006276_abnormal_autonomic_nervous | 2.23764979 |
| 24 | MP0002064_seizures | 2.22013089 |
| 25 | MP0005083_abnormal_biliary_tract | 2.16946939 |
| 26 | MP0004858_abnormal_nervous_system | 2.15274117 |
| 27 | MP0002733_abnormal_thermal_nociception | 2.11828061 |
| 28 | MP0002909_abnormal_adrenal_gland | 2.07134698 |
| 29 | MP0003303_peritoneal_inflammation | 2.01750856 |
| 30 | MP0009046_muscle_twitch | 1.91659263 |
| 31 | MP0003436_decreased_susceptibility_to | 1.91502147 |
| 32 | MP0002272_abnormal_nervous_system | 1.89560377 |
| 33 | MP0002572_abnormal_emotion/affect_behav | 1.79113899 |
| 34 | MP0002132_abnormal_respiratory_system | 1.78787583 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.75906973 |
| 36 | MP0001970_abnormal_pain_threshold | 1.75581795 |
| 37 | MP0004147_increased_porphyrin_level | 1.74738398 |
| 38 | MP0003186_abnormal_redox_activity | 1.73922340 |
| 39 | MP0004510_myositis | 1.72638476 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.70767352 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.68030640 |
| 42 | MP0005671_abnormal_response_to | 1.62103844 |
| 43 | MP0005332_abnormal_amino_acid | 1.60366578 |
| 44 | MP0008872_abnormal_physiological_respon | 1.58880222 |
| 45 | MP0002163_abnormal_gland_morphology | 1.57203181 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.54130713 |
| 47 | MP0001984_abnormal_olfaction | 1.53606578 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.52490241 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.49200654 |
| 50 | MP0009840_abnormal_foam_cell | 1.48882928 |
| 51 | MP0004811_abnormal_neuron_physiology | 1.48846709 |
| 52 | MP0004924_abnormal_behavior | 1.48062987 |
| 53 | MP0005386_behavior/neurological_phenoty | 1.48062987 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.43956510 |
| 55 | MP0001346_abnormal_lacrimal_gland | 1.43186433 |
| 56 | MP0004043_abnormal_pH_regulation | 1.43159948 |
| 57 | MP0002067_abnormal_sensory_capabilities | 1.42915192 |
| 58 | MP0000604_amyloidosis | 1.42212763 |
| 59 | MP0003123_paternal_imprinting | 1.41837828 |
| 60 | MP0004233_abnormal_muscle_weight | 1.41163109 |
| 61 | MP0001666_abnormal_nutrient_absorption | 1.40949675 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 1.36076602 |
| 63 | MP0005535_abnormal_body_temperature | 1.35495932 |
| 64 | MP0001440_abnormal_grooming_behavior | 1.35315880 |
| 65 | MP0000751_myopathy | 1.33948802 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.33161376 |
| 67 | MP0009785_altered_susceptibility_to | 1.32401259 |
| 68 | MP0005025_abnormal_response_to | 1.31139149 |
| 69 | MP0005423_abnormal_somatic_nervous | 1.30935068 |
| 70 | MP0009278_abnormal_bone_marrow | 1.29648399 |
| 71 | MP0000858_altered_metastatic_potential | 1.29162755 |
| 72 | MP0002184_abnormal_innervation | 1.28916674 |
| 73 | MP0006035_abnormal_mitochondrial_morpho | 1.27843436 |
| 74 | MP0003646_muscle_fatigue | 1.25998569 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.25637229 |
| 76 | MP0000678_abnormal_parathyroid_gland | 1.24120325 |
| 77 | MP0006082_CNS_inflammation | 1.23958790 |
| 78 | MP0000490_abnormal_crypts_of | 1.23046931 |
| 79 | MP0008569_lethality_at_weaning | 1.23015450 |
| 80 | MP0005166_decreased_susceptibility_to | 1.22156137 |
| 81 | MP0001486_abnormal_startle_reflex | 1.21993605 |
| 82 | MP0000343_altered_response_to | 1.20678206 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20348421 |
| 84 | MP0005464_abnormal_platelet_physiology | 1.20332974 |
| 85 | MP0001905_abnormal_dopamine_level | 1.20079431 |
| 86 | MP0003879_abnormal_hair_cell | 1.19450930 |
| 87 | MP0001529_abnormal_vocalization | 1.18699486 |
| 88 | * MP0005000_abnormal_immune_tolerance | 1.17301083 |
| 89 | MP0001348_abnormal_lacrimal_gland | 1.15623462 |
| 90 | MP0002557_abnormal_social/conspecific_i | 1.14721379 |
| 91 | MP0003633_abnormal_nervous_system | 1.13350890 |
| 92 | MP0003195_calcinosis | 1.11362073 |
| 93 | MP0005623_abnormal_meninges_morphology | 1.11317699 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 1.10808153 |
| 95 | MP0000750_abnormal_muscle_regeneration | 1.10780423 |
| 96 | MP0002066_abnormal_motor_capabilities/c | 1.10762805 |
| 97 | MP0004885_abnormal_endolymph | 1.10053936 |
| 98 | MP0000955_abnormal_spinal_cord | 1.09868493 |
| 99 | MP0004130_abnormal_muscle_cell | 1.08276680 |
| 100 | MP0004142_abnormal_muscle_tone | 1.07281346 |
| 101 | MP0000358_abnormal_cell_content/ | 1.06490002 |
| 102 | MP0002419_abnormal_innate_immunity | 1.02351767 |
| 103 | MP0004145_abnormal_muscle_electrophysio | 1.02046912 |
| 104 | MP0001835_abnormal_antigen_presentation | 1.01903608 |
| 105 | MP0000681_abnormal_thyroid_gland | 1.01684444 |
| 106 | MP0004215_abnormal_myocardial_fiber | 1.01613939 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 1.00734540 |
| 108 | MP0001727_abnormal_embryo_implantation | 0.99748235 |
| 109 | MP0008874_decreased_physiological_sensi | 0.99526707 |
| 110 | MP0002420_abnormal_adaptive_immunity | 0.96619145 |
| 111 | MP0001819_abnormal_immune_cell | 0.94481666 |
| 112 | * MP0002723_abnormal_immune_serum | 0.94333851 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.92327031 |
| 114 | MP0000747_muscle_weakness | 0.92015898 |
| 115 | MP0000685_abnormal_immune_system | 0.91906005 |
| 116 | MP0002078_abnormal_glucose_homeostasis | 0.89924586 |
| 117 | MP0008961_abnormal_basal_metabolism | 0.89135139 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.88868005 |
| 119 | MP0003631_nervous_system_phenotype | 0.87994722 |
| 120 | MP0003634_abnormal_glial_cell | 0.86867697 |
| 121 | MP0002229_neurodegeneration | 0.86728330 |
| 122 | MP0004185_abnormal_adipocyte_glucose | 0.86470565 |
| 123 | MP0002882_abnormal_neuron_morphology | 0.86112093 |
| 124 | MP0005379_endocrine/exocrine_gland_phen | 0.84811910 |
| 125 | MP0000920_abnormal_myelination | 0.84660584 |
| 126 | MP0005084_abnormal_gallbladder_morpholo | 0.84185515 |
| 127 | MP0005394_taste/olfaction_phenotype | 0.84116569 |
| 128 | MP0005499_abnormal_olfactory_system | 0.84116569 |
| 129 | MP0000749_muscle_degeneration | 0.84085278 |
| 130 | MP0003252_abnormal_bile_duct | 0.83572664 |
| 131 | MP0010234_abnormal_vibrissa_follicle | 0.82508797 |
| 132 | MP0000778_abnormal_nervous_system | 0.81352313 |
| 133 | MP0003283_abnormal_digestive_organ | 0.81232259 |
| 134 | MP0002138_abnormal_hepatobiliary_system | 0.81149191 |
| 135 | MP0002277_abnormal_respiratory_mucosa | 0.80944134 |
| 136 | MP0002069_abnormal_eating/drinking_beha | 0.80889717 |
| 137 | MP0009643_abnormal_urine_homeostasis | 0.79538252 |
| 138 | MP0001765_abnormal_ion_homeostasis | 0.79119725 |
| 139 | MP0003693_abnormal_embryo_hatching | 0.78796111 |
| 140 | MP0008469_abnormal_protein_level | 0.78544944 |
| 141 | MP0005501_abnormal_skin_physiology | 0.78337209 |
| 142 | MP0002269_muscular_atrophy | 0.78215037 |
| 143 | MP0005165_increased_susceptibility_to | 0.78143263 |
| 144 | MP0002452_abnormal_antigen_presenting | 0.77789333 |
| 145 | * MP0002398_abnormal_bone_marrow | 0.76721183 |
| 146 | MP0004085_abnormal_heartbeat | 0.76378111 |
| 147 | MP0005646_abnormal_pituitary_gland | 0.76128362 |
| 148 | MP0008789_abnormal_olfactory_epithelium | 0.75960649 |
| 149 | MP0000465_gastrointestinal_hemorrhage | 0.75893674 |
| 150 | MP0004036_abnormal_muscle_relaxation | 0.75645996 |
| 151 | MP0005167_abnormal_blood-brain_barrier | 0.74506780 |
| 152 | MP0003137_abnormal_impulse_conducting | 0.74478130 |
| 153 | MP0005330_cardiomyopathy | 0.74266195 |
| 154 | MP0009764_decreased_sensitivity_to | 0.73664687 |
| 155 | MP0003868_abnormal_feces_composition | 0.73279161 |
| 156 | MP0003075_altered_response_to | 0.72621663 |
| 157 | MP0000759_abnormal_skeletal_muscle | 0.72129945 |
| 158 | MP0002876_abnormal_thyroid_physiology | 0.71889662 |
| 159 | MP0001764_abnormal_homeostasis | 0.71474515 |
| 160 | MP0001853_heart_inflammation | 0.71336661 |
| 161 | * MP0002429_abnormal_blood_cell | 0.71105617 |
| 162 | MP0001756_abnormal_urination | 0.71070885 |
| 163 | * MP0000716_abnormal_immune_system | 0.70957393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.95710284 |
| 2 | Focal motor seizures (HP:0011153) | 4.12475583 |
| 3 | Visual hallucinations (HP:0002367) | 4.10333765 |
| 4 | Increased intramyocellular lipid droplets (HP:0012240) | 4.05102866 |
| 5 | Increased muscle lipid content (HP:0009058) | 3.81589256 |
| 6 | Pheochromocytoma (HP:0002666) | 3.56665264 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 3.47949217 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.47949217 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.47949217 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.32770796 |
| 11 | Neuroendocrine neoplasm (HP:0100634) | 3.32245448 |
| 12 | Gout (HP:0001997) | 3.27789496 |
| 13 | Focal seizures (HP:0007359) | 3.07322160 |
| 14 | Ketosis (HP:0001946) | 3.03390377 |
| 15 | Ketoacidosis (HP:0001993) | 2.96150565 |
| 16 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.95726382 |
| 17 | Exercise intolerance (HP:0003546) | 2.95093766 |
| 18 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.94449216 |
| 19 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.85370073 |
| 20 | Acute encephalopathy (HP:0006846) | 2.81924375 |
| 21 | Ankle clonus (HP:0011448) | 2.80169575 |
| 22 | Poor eye contact (HP:0000817) | 2.75558910 |
| 23 | Absence seizures (HP:0002121) | 2.68597952 |
| 24 | Impaired social interactions (HP:0000735) | 2.67186313 |
| 25 | Abnormal social behavior (HP:0012433) | 2.67186313 |
| 26 | Microretrognathia (HP:0000308) | 2.66372555 |
| 27 | Hyperammonemia (HP:0001987) | 2.62004467 |
| 28 | Acute necrotizing encephalopathy (HP:0006965) | 2.60663096 |
| 29 | Abnormal gallbladder physiology (HP:0012438) | 2.60602544 |
| 30 | Cholecystitis (HP:0001082) | 2.60602544 |
| 31 | Anxiety (HP:0000739) | 2.60405879 |
| 32 | Supranuclear gaze palsy (HP:0000605) | 2.60250691 |
| 33 | Atonic seizures (HP:0010819) | 2.59382245 |
| 34 | Neuronal loss in central nervous system (HP:0002529) | 2.56782483 |
| 35 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.53792251 |
| 36 | Hyperventilation (HP:0002883) | 2.51839613 |
| 37 | Mutism (HP:0002300) | 2.50951609 |
| 38 | Epileptic encephalopathy (HP:0200134) | 2.49871158 |
| 39 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.49424710 |
| 40 | Hyperglycinemia (HP:0002154) | 2.49209250 |
| 41 | Myopathic facies (HP:0002058) | 2.49082759 |
| 42 | Nasal polyposis (HP:0100582) | 2.47902496 |
| 43 | Increased IgM level (HP:0003496) | 2.46884692 |
| 44 | Depression (HP:0000716) | 2.46396424 |
| 45 | Progressive muscle weakness (HP:0003323) | 2.45749776 |
| 46 | Hypertensive crisis (HP:0100735) | 2.42945925 |
| 47 | Increased hepatocellular lipid droplets (HP:0006565) | 2.42649925 |
| 48 | Cerebral edema (HP:0002181) | 2.41455387 |
| 49 | Generalized tonic-clonic seizures (HP:0002069) | 2.39176445 |
| 50 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.38740203 |
| 51 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.38740203 |
| 52 | Delusions (HP:0000746) | 2.38575298 |
| 53 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.38067791 |
| 54 | Testicular atrophy (HP:0000029) | 2.36698365 |
| 55 | Progressive neurologic deterioration (HP:0002344) | 2.35829361 |
| 56 | Renal Fanconi syndrome (HP:0001994) | 2.34285128 |
| 57 | Hepatic necrosis (HP:0002605) | 2.33144679 |
| 58 | Dialeptic seizures (HP:0011146) | 2.31834226 |
| 59 | Hepatocellular necrosis (HP:0001404) | 2.30774789 |
| 60 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.30622565 |
| 61 | Cholelithiasis (HP:0001081) | 2.26311988 |
| 62 | Hyperglycinuria (HP:0003108) | 2.26197926 |
| 63 | Lipid accumulation in hepatocytes (HP:0006561) | 2.25759593 |
| 64 | Action tremor (HP:0002345) | 2.24455585 |
| 65 | Focal dystonia (HP:0004373) | 2.24151885 |
| 66 | Distal lower limb muscle weakness (HP:0009053) | 2.23403974 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.22602836 |
| 68 | Urinary urgency (HP:0000012) | 2.22323321 |
| 69 | Lactic acidosis (HP:0003128) | 2.22108071 |
| 70 | Abnormality of the lower motor neuron (HP:0002366) | 2.22078277 |
| 71 | Ventricular fibrillation (HP:0001663) | 2.21886121 |
| 72 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.21556415 |
| 73 | Vertebral compression fractures (HP:0002953) | 2.21439873 |
| 74 | Craniofacial dystonia (HP:0012179) | 2.21213509 |
| 75 | Mitochondrial inheritance (HP:0001427) | 2.20938376 |
| 76 | Global brain atrophy (HP:0002283) | 2.19904727 |
| 77 | Abnormal eating behavior (HP:0100738) | 2.19430140 |
| 78 | Myoglobinuria (HP:0002913) | 2.19347223 |
| 79 | Status epilepticus (HP:0002133) | 2.19279197 |
| 80 | Increased serum lactate (HP:0002151) | 2.18580756 |
| 81 | Exercise-induced myalgia (HP:0003738) | 2.17933007 |
| 82 | Ragged-red muscle fibers (HP:0003200) | 2.17511502 |
| 83 | Cerebral hypomyelination (HP:0006808) | 2.17458559 |
| 84 | Microvesicular hepatic steatosis (HP:0001414) | 2.16949367 |
| 85 | Progressive macrocephaly (HP:0004481) | 2.16590837 |
| 86 | Neonatal onset (HP:0003623) | 2.15679592 |
| 87 | Growth hormone excess (HP:0000845) | 2.14661414 |
| 88 | Abnormal gallbladder morphology (HP:0012437) | 2.14048067 |
| 89 | Upper motor neuron abnormality (HP:0002127) | 2.13842760 |
| 90 | Progressive inability to walk (HP:0002505) | 2.12967372 |
| 91 | Obstructive lung disease (HP:0006536) | 2.12784131 |
| 92 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12784131 |
| 93 | Xanthomatosis (HP:0000991) | 2.12210191 |
| 94 | Abnormality of glycine metabolism (HP:0010895) | 2.11366528 |
| 95 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.11366528 |
| 96 | Loss of speech (HP:0002371) | 2.11120369 |
| 97 | Degeneration of anterior horn cells (HP:0002398) | 2.11028578 |
| 98 | Abnormality of the anterior horn cell (HP:0006802) | 2.11028578 |
| 99 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10777721 |
| 100 | Hypobetalipoproteinemia (HP:0003563) | 2.10726682 |
| 101 | Respiratory failure (HP:0002878) | 2.10693238 |
| 102 | Respiratory difficulties (HP:0002880) | 2.09401138 |
| 103 | Delayed CNS myelination (HP:0002188) | 2.09094539 |
| 104 | Lethargy (HP:0001254) | 2.08951930 |
| 105 | Petechiae (HP:0000967) | 2.08205952 |
| 106 | Torticollis (HP:0000473) | 2.08020603 |
| 107 | Hyperlipoproteinemia (HP:0010980) | 2.06309062 |
| 108 | Diminished motivation (HP:0000745) | 2.06285612 |
| 109 | Abnormality of the motor neurons (HP:0002450) | 2.05830857 |
| 110 | Abnormal neuron morphology (HP:0012757) | 2.05830857 |
| 111 | Hypsarrhythmia (HP:0002521) | 2.04148329 |
| 112 | Metabolic acidosis (HP:0001942) | 2.03584719 |
| 113 | Rhabdomyolysis (HP:0003201) | 2.03573181 |
| 114 | Intrahepatic cholestasis (HP:0001406) | 2.02821647 |
| 115 | Myotonia (HP:0002486) | 2.02672704 |
| 116 | Poor suck (HP:0002033) | 2.02583963 |
| 117 | EEG with generalized epileptiform discharges (HP:0011198) | 2.02415863 |
| 118 | Increased CSF lactate (HP:0002490) | 2.01538466 |
| 119 | Epileptiform EEG discharges (HP:0011182) | 2.01236463 |
| 120 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.01179407 |
| 121 | Purpura (HP:0000979) | 2.01157496 |
| 122 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.00698964 |
| 123 | Abnormality of the Achilles tendon (HP:0005109) | 2.00499838 |
| 124 | Palpitations (HP:0001962) | 2.00173150 |
| 125 | Achilles tendon contracture (HP:0001771) | 1.99850731 |
| 126 | Impaired pain sensation (HP:0007328) | 1.98954304 |
| 127 | Abnormality of pain sensation (HP:0010832) | 1.98954304 |
| 128 | Hand muscle atrophy (HP:0009130) | 1.98459697 |
| 129 | Truncal ataxia (HP:0002078) | 1.96494358 |
| 130 | Muscular hypotonia of the trunk (HP:0008936) | 1.96147689 |
| 131 | Febrile seizures (HP:0002373) | 1.95180078 |
| 132 | Apathy (HP:0000741) | 1.94461294 |
| 133 | Emotional lability (HP:0000712) | 1.92996949 |
| 134 | Abnormality of macrophages (HP:0004311) | 1.92529818 |
| 135 | Polyphagia (HP:0002591) | 1.91796347 |
| 136 | Upper limb amyotrophy (HP:0009129) | 1.90728463 |
| 137 | Distal upper limb amyotrophy (HP:0007149) | 1.90728463 |
| 138 | Bradykinesia (HP:0002067) | 1.90018543 |
| 139 | Deep venous thrombosis (HP:0002625) | 1.89910491 |
| 140 | Tetraplegia (HP:0002445) | 1.89834454 |
| 141 | Athetosis (HP:0002305) | 1.89264949 |
| 142 | Dysphonia (HP:0001618) | 1.89169848 |
| 143 | Progressive microcephaly (HP:0000253) | 1.89166160 |
| 144 | Oligomenorrhea (HP:0000876) | 1.88813872 |
| 145 | Multiple enchondromatosis (HP:0005701) | 1.87488503 |
| 146 | Late onset (HP:0003584) | 1.85967162 |
| 147 | Mediastinal lymphadenopathy (HP:0100721) | 1.84632457 |
| 148 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84449691 |
| 149 | Dicarboxylic aciduria (HP:0003215) | 1.84449691 |
| 150 | Hyperbilirubinemia (HP:0002904) | 1.84211830 |
| 151 | Fatigue (HP:0012378) | 1.84099761 |
| 152 | Spastic gait (HP:0002064) | 1.84076576 |
| 153 | Abnormality of the vocal cords (HP:0008777) | 1.83864568 |
| 154 | Unsteady gait (HP:0002317) | 1.83819559 |
| 155 | Amblyopia (HP:0000646) | 1.83392645 |
| 156 | Hypoglycemic coma (HP:0001325) | 1.83354003 |
| 157 | Progressive cerebellar ataxia (HP:0002073) | 1.83138605 |
| 158 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.82502053 |
| 159 | Hepatosplenomegaly (HP:0001433) | 1.82410647 |
| 160 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.81501544 |
| 161 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.79741719 |
| 162 | Neurofibrillary tangles (HP:0002185) | 1.79631947 |
| 163 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.79613053 |
| 164 | Truncus arteriosus (HP:0001660) | 1.79295553 |
| 165 | Hyperthyroidism (HP:0000836) | 1.79165892 |
| 166 | Amyloidosis (HP:0011034) | 1.77656069 |
| 167 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.74837500 |
| 168 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.74837500 |
| 169 | Dementia (HP:0000726) | 1.73494716 |
| 170 | Gliosis (HP:0002171) | 1.72919887 |
| 171 | Dysostosis multiplex (HP:0000943) | 1.72259645 |
| 172 | Abnormality of glycolysis (HP:0004366) | 1.72013766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 4.03241206 |
| 2 | NME2 | 3.77285769 |
| 3 | MAP3K9 | 3.75168210 |
| 4 | NTRK3 | 3.31482462 |
| 5 | LMTK2 | 3.29013864 |
| 6 | MINK1 | 3.07767221 |
| 7 | MAP3K12 | 3.00613275 |
| 8 | MAP3K4 | 2.72550351 |
| 9 | MAP2K4 | 2.65549306 |
| 10 | DAPK2 | 2.62172375 |
| 11 | BCKDK | 2.60569134 |
| 12 | KSR2 | 2.54553438 |
| 13 | MARK1 | 2.50766384 |
| 14 | PIM2 | 2.30574113 |
| 15 | NTRK1 | 2.25451679 |
| 16 | MAP2K7 | 2.24821573 |
| 17 | EPHA4 | 2.20342431 |
| 18 | TAOK2 | 2.12422917 |
| 19 | SCYL2 | 1.99409932 |
| 20 | VRK2 | 1.89457155 |
| 21 | DAPK1 | 1.88045944 |
| 22 | PRPF4B | 1.84562663 |
| 23 | ARAF | 1.84389458 |
| 24 | KSR1 | 1.83861615 |
| 25 | IRAK3 | 1.77550276 |
| 26 | MAP3K2 | 1.76732683 |
| 27 | KDR | 1.75310464 |
| 28 | PINK1 | 1.75045341 |
| 29 | SMG1 | 1.70926256 |
| 30 | CDK19 | 1.62826990 |
| 31 | NEK1 | 1.62203940 |
| 32 | GRK5 | 1.61016107 |
| 33 | STK16 | 1.57101100 |
| 34 | NME1 | 1.56330526 |
| 35 | PHKG2 | 1.49558202 |
| 36 | PHKG1 | 1.49558202 |
| 37 | RIPK4 | 1.41667914 |
| 38 | PAK6 | 1.39338035 |
| 39 | CDK5 | 1.36793673 |
| 40 | SIK3 | 1.34387097 |
| 41 | TBK1 | 1.28609280 |
| 42 | MAP4K1 | 1.25432639 |
| 43 | CAMKK1 | 1.23495979 |
| 44 | EIF2AK1 | 1.22795417 |
| 45 | MAP3K11 | 1.21572932 |
| 46 | NTRK2 | 1.19976421 |
| 47 | RET | 1.16658392 |
| 48 | PRKCG | 1.12695753 |
| 49 | MAP2K3 | 1.11987958 |
| 50 | PRKD3 | 1.11725571 |
| 51 | TLK1 | 1.07400640 |
| 52 | AURKA | 1.03350694 |
| 53 | TRIB3 | 1.02217557 |
| 54 | UHMK1 | 1.01872016 |
| 55 | WNK4 | 0.99894020 |
| 56 | BUB1 | 0.99837165 |
| 57 | FES | 0.98551831 |
| 58 | MAP2K1 | 0.96171691 |
| 59 | STK38 | 0.95053609 |
| 60 | DYRK1B | 0.93472267 |
| 61 | MAP3K3 | 0.91775294 |
| 62 | LATS2 | 0.90652916 |
| 63 | MAP3K1 | 0.89249964 |
| 64 | SRPK1 | 0.87476036 |
| 65 | PAK4 | 0.87132195 |
| 66 | PRKD2 | 0.86557630 |
| 67 | DAPK3 | 0.86049062 |
| 68 | LIMK1 | 0.84704940 |
| 69 | LRRK2 | 0.82309273 |
| 70 | MAP2K6 | 0.82244900 |
| 71 | PAK1 | 0.81457469 |
| 72 | CSNK1G3 | 0.81148947 |
| 73 | CDK14 | 0.78788639 |
| 74 | GRK6 | 0.77664862 |
| 75 | CDK18 | 0.77396655 |
| 76 | MAPKAPK3 | 0.76839534 |
| 77 | RAF1 | 0.76739538 |
| 78 | MATK | 0.76024489 |
| 79 | PDPK1 | 0.75328374 |
| 80 | TAOK1 | 0.74340445 |
| 81 | SGK223 | 0.74150266 |
| 82 | SGK494 | 0.74150266 |
| 83 | PDK3 | 0.69706225 |
| 84 | PDK4 | 0.69706225 |
| 85 | CDK15 | 0.69489386 |
| 86 | CAMK2G | 0.69251266 |
| 87 | CAMKK2 | 0.68992827 |
| 88 | PDK1 | 0.65371167 |
| 89 | MARK2 | 0.62557348 |
| 90 | PRKCH | 0.62104371 |
| 91 | CDK11A | 0.61967638 |
| 92 | PKN1 | 0.61846678 |
| 93 | SIK2 | 0.61458430 |
| 94 | PTK2B | 0.60525222 |
| 95 | ILK | 0.60509901 |
| 96 | EPHA2 | 0.60335822 |
| 97 | PRKCZ | 0.60094621 |
| 98 | BRAF | 0.59330548 |
| 99 | ABL2 | 0.59262699 |
| 100 | ICK | 0.59230456 |
| 101 | TYK2 | 0.57506019 |
| 102 | CAMK2A | 0.57482788 |
| 103 | MAP3K5 | 0.57362891 |
| 104 | PLK2 | 0.57147212 |
| 105 | MAPK13 | 0.54362786 |
| 106 | CSK | 0.53867577 |
| 107 | PRKG2 | 0.52550519 |
| 108 | IRAK2 | 0.51785113 |
| 109 | CSNK1G2 | 0.51643422 |
| 110 | PAK3 | 0.51077666 |
| 111 | PKN2 | 0.50697085 |
| 112 | MAP2K2 | 0.50520434 |
| 113 | CAMK2B | 0.50489015 |
| 114 | CSNK1A1L | 0.48627561 |
| 115 | IRAK4 | 0.47534664 |
| 116 | OXSR1 | 0.47387270 |
| 117 | ERN1 | 0.47360879 |
| 118 | AKT2 | 0.46931032 |
| 119 | CAMK1 | 0.44693485 |
| 120 | TESK1 | 0.44529671 |
| 121 | MAP3K7 | 0.43474617 |
| 122 | WNK3 | 0.43345360 |
| 123 | STK24 | 0.42686296 |
| 124 | MAPK12 | 0.42481860 |
| 125 | MOS | 0.42406352 |
| 126 | RPS6KA2 | 0.42192908 |
| 127 | CAMK2D | 0.39444169 |
| 128 | MAP3K13 | 0.39338790 |
| 129 | CCNB1 | 0.38584649 |
| 130 | PRKACG | 0.38455891 |
| 131 | MAP3K8 | 0.37540481 |
| 132 | FGR | 0.36505006 |
| 133 | STK11 | 0.35096534 |
| 134 | TRIM28 | 0.34861760 |
| 135 | FER | 0.34814049 |
| 136 | PBK | 0.34728479 |
| 137 | PRKCD | 0.33945202 |
| 138 | MAPKAPK5 | 0.33906737 |
| 139 | DYRK1A | 0.32639410 |
| 140 | PRKCI | 0.32325455 |
| 141 | BCR | 0.32255950 |
| 142 | PNCK | 0.31526093 |
| 143 | MYLK | 0.31304263 |
| 144 | DYRK2 | 0.30213844 |
| 145 | EPHB1 | 0.29871248 |
| 146 | TNK2 | 0.26116958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.19362178 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.98228146 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.88787157 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.82362518 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.34488368 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.29973117 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.20342707 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.13160529 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.05764212 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.04830890 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.99156118 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 1.96198696 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94468577 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.93879024 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.87828789 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.85849668 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83151992 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.76793461 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.76455652 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.74373565 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.65092616 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64768925 |
| 23 | Nicotine addiction_Homo sapiens_hsa05033 | 1.59998518 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.56082675 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.53278905 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.52520703 |
| 27 | Long-term potentiation_Homo sapiens_hsa04720 | 1.51615862 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.51091592 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.49687558 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.46854449 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45676485 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.43648065 |
| 33 | Alzheimers disease_Homo sapiens_hsa05010 | 1.42207596 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41546876 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41536582 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.39440002 |
| 37 | Insulin secretion_Homo sapiens_hsa04911 | 1.36950294 |
| 38 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.35121296 |
| 39 | RNA polymerase_Homo sapiens_hsa03020 | 1.35036472 |
| 40 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.34048214 |
| 41 | Circadian entrainment_Homo sapiens_hsa04713 | 1.33941213 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.32928946 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.32655277 |
| 44 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.31856711 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.31160101 |
| 46 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.30416992 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.23854092 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18263918 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.17301446 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.16784944 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15930249 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.15803820 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.14320091 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.13569501 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12886085 |
| 56 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09410002 |
| 57 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.09095986 |
| 58 | Spliceosome_Homo sapiens_hsa03040 | 1.08763876 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.07317428 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07298050 |
| 61 | Peroxisome_Homo sapiens_hsa04146 | 1.05797140 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05674660 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05381732 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04906643 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 1.04651668 |
| 66 | Huntingtons disease_Homo sapiens_hsa05016 | 1.01957374 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.01708954 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00677160 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96074629 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.94213938 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.94074335 |
| 72 | Mismatch repair_Homo sapiens_hsa03430 | 0.92677352 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91762658 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.91646730 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90560082 |
| 76 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89808271 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87963391 |
| 78 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.87560127 |
| 79 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.87557595 |
| 80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86824730 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.85302244 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85000971 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84568769 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82768392 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81043017 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80131570 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79715258 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79265881 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72729449 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72581389 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.70316454 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.70215470 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69900703 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68973470 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67541554 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67111423 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65850651 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64996780 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63985457 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63486241 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63388172 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63364373 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62946029 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61927360 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.60954620 |
| 106 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.60403250 |
| 107 | Renin secretion_Homo sapiens_hsa04924 | 0.59752637 |
| 108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59685597 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57917584 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.57887696 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57203727 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56999972 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56668887 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56093772 |
| 115 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54655366 |
| 116 | Tuberculosis_Homo sapiens_hsa05152 | 0.54315716 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52822651 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.51741601 |
| 119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50124523 |
| 120 | Long-term depression_Homo sapiens_hsa04730 | 0.49905874 |
| 121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49187381 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48045761 |
| 123 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.47117585 |
| 124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46997908 |
| 125 | Purine metabolism_Homo sapiens_hsa00230 | 0.46092569 |
| 126 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.45956795 |
| 127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45215263 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44950457 |
| 129 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44675184 |
| 130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43989269 |
| 131 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40460107 |
| 132 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.40396307 |
| 133 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.40384708 |
| 134 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40322655 |
| 135 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39963537 |
| 136 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38702268 |
| 137 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37509420 |
| 138 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36384658 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35826667 |
| 140 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.35810587 |
| 141 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.35722759 |
| 142 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35496340 |
| 143 | Legionellosis_Homo sapiens_hsa05134 | 0.35133950 |
| 144 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35089366 |
| 145 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.33222159 |
| 146 | Viral myocarditis_Homo sapiens_hsa05416 | 0.32252114 |
| 147 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31549668 |
| 148 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30866897 |
| 149 | Allograft rejection_Homo sapiens_hsa05330 | 0.30459251 |
| 150 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30201643 |
| 151 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29056350 |
| 152 | Bladder cancer_Homo sapiens_hsa05219 | 0.28927985 |
| 153 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28489398 |
| 154 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.25990290 |
| 155 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.25651686 |
| 156 | Alcoholism_Homo sapiens_hsa05034 | 0.22709063 |

